Barinthus Biotherapeutics Plc
(NASDAQ) VACC
Barinthus Biotherapeutics Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$66.43M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
VACC News
VACC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Barinthus Biotherapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
William Enright
Website
vaccitech.co.ukHeadquarters
Oxford, OX4 4GE, GB
VACC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-71%
Return on Capital
-61%
Return on Assets
-68%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$506.00K
EBITDA
$506.00K
Operating Cash Flow
$47.98M
Capital Expenditure
$37.00K
Free Cash Flow
$48.02M
Cash & ST Invst.
$70.46M
Total Debt
$11.28M
Barinthus Biotherapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
33
N/A
Net Income
$11.09M
-122.8%
EBITDA
$8.00K
+100.1%
Quarterly Fundamentals
Net Cash
$59.17M
-40.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$9.26M
-8.2%
Short Term Debt
$2.02M
+5.4%
Return on Assets
-67.67%
N/A
Return on Invested Capital
-61.48%
N/A
Free Cash Flow
$4.24M
-160.1%
Operating Cash Flow
$4.24M
-278.1%